论文信息 - Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer - 字舞流文

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer

Kelvin K. W. Chan | J. Biagi | M. Raphael | S. Habbous | N. Mittmann | W. Isaranuwatchai | S. Gavura | A. Parmar | Jin Luo | J. Beca | M. Tadrous | W. Dai | Jessica Arias | V. Arciero | C. Earle | J. Arias